NANOBIOTIX : promising data from phase I/II Head and Neck cancer trial with NBTXR3 presented at the American ... - GlobeNewswire (press release)

NANOBIOTIX : promising data from phase I/II Head and Neck cancer trial with NBTXR3 presented at the American ... GlobeNewswire (press release) Head and neck cancers represent a group of aggressive cancers that appear in the mouth, nose, sinuses and at the top of the aerodigestive tract. This disease is a major public health concern in USA, Europe and Asia. Nanobiotix's Phase I/II head and ... and more »

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2sTsGkb
via IFTTT